We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+4.79%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$10.9B
AUM Growth
+$843M
(+8.4%)
Cap. Flow
+$426M
Cap. Flow
% of AUM
3.92%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
1,453
New
18
Increased
663
Reduced
669
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$32.9M |
| 2 |
Microsoft
MSFT
|
+$24.3M |
| 3 |
Amazon
AMZN
|
+$21.5M |
| 4 |
Meta Platforms (Facebook)
META
|
+$17.4M |
| 5 |
DuPont de Nemours
DD
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$16.3M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$13.1M |
| 3 |
A.O. Smith
AOS
|
+$9.9M |
| 4 |
S&P Global
SPGI
|
+$8.24M |
| 5 |
AbbVie
ABBV
|
+$6.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.75% |
| 2 | Financials | 14.74% |
| 3 | Technology | 14.3% |
| 4 | Consumer Staples | 10.87% |
| 5 | Industrials | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
MacroGenics
MGNX
$255M
| $426K | ﹤0.01% |
23,056
+2,145
| +10% | +$37.2K |
|
|
AMAG
1027
DELISTED
AMAG Pharmaceuticals
AMAG
| $424K | ﹤0.01% |
22,974
+1,364
| +6% | +$25.4K |
|
|
ITCI
1028
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $423K | ﹤0.01% |
26,776
+1,507
| +6% | +$22.1K |
|
|
RICE
1029
DELISTED
Rice Energy Inc.
RICE
| $423K | ﹤0.01% |
14,623
-550
| -4% | -$15K |
|
1030
CACI
CACI
$10.6B
| $419K | ﹤0.01% |
3,008
-440
| -13% | -$56.8K |
|
1031
Teradata
TDC
$2.6B
| $418K | ﹤0.01% |
12,382
-18,416
| -60% | -$572K |
|
1032
JetBlue
JBLU
$1.86B
| $416K | ﹤0.01% |
22,456
-2,128
| -9% | -$44.6K |
|
1033
Prestige Consumer Healthcare
PBH
$2.32B
| $416K | ﹤0.01% |
8,306
-1,176
| -12% | -$60.1K |
|
1034
Thor Industries
THO
$3.9B
| $416K | ﹤0.01% |
3,307
-226
| -6% | -$24.4K |
|
1035
Commault Systems
CVLT
$5.85B
| $415K | ﹤0.01% |
6,820
-1,024
| -13% | -$61.1K |
|
1036
EnerSys
ENS
$7.29B
| $414K | ﹤0.01% |
5,984
-1,125
| -16% | -$77K |
|
|
SGYP
1037
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $413K | ﹤0.01% |
142,291
+6,788
| +5% | +$23.2K |
|
1038
Capitol Federal Financial
CFFN
$1.06B
| $411K | ﹤0.01% |
27,974
-1,701
| -6% | -$23.7K |
|
1039
Jack in the Box
JACK
$263M
| $411K | ﹤0.01% |
4,034
-931
| -19% | -$89K |
|
1040
TripAdvisor
TRIP
$1.57B
| $410K | ﹤0.01% |
10,114
+1,239
| +14% | +$50.3K |
|
1041
Live Nation Entertainment
LYV
$41B
| $406K | ﹤0.01% |
9,327
-705
| -7% | -$27.4K |
|
1042
Lumentum
LITE
$64.9B
| $405K | ﹤0.01% |
7,452
-801
| -10% | -$46.6K |
|
1043
Aecom
ACM
$8.69B
| $401K | ﹤0.01% |
10,898
-872
| -7% | -$28.7K |
|
1044
Avis
CAR
$5.62B
| $400K | ﹤0.01% |
10,500
-2,736
| -21% | -$92K |
|
1045
Post Holdings
POST
$4.09B
| $396K | ﹤0.01% |
6,852
-623
| -8% | -$34.1K |
|
|
ESV
1046
DELISTED
Ensco Rowan plc
ESV
| $396K | ﹤0.01% |
16,587
-2,430
| -13% | -$48.5K |
|
1047
Bio-Rad Laboratories Class A
BIO
$8.47B
| $395K | ﹤0.01% |
1,777
-112
| -6% | -$25.2K |
|
1048
Worthington Enterprises
WOR
$2.72B
| $395K | ﹤0.01% |
13,939
-1,864
| -12% | -$58K |
|
|
COHR
1049
DELISTED
Coherent Inc
COHR
| $394K | ﹤0.01% |
1,675
-27
| -2% | -$6.51K |
|
1050
Zebra Technologies
ZBRA
$12.2B
| $392K | ﹤0.01% |
3,610
-289
| -7% | -$29.7K |
|
Similar funds
ProShare Advisors's Q3 2017 Portfolio in Review
As of Q3 2017, ProShare Advisors held 1,453 positions worth $10.9B, up 8.4% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
ProShare Advisors deployed $426M of net new capital in Q3 2017, opening 18 new positions and adding to 663 existing holdings. Its largest new stake was Baker Hughes: 116,604 shares worth $4.27M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was CR Bard Inc., an estimated $13.1M trimmed.
- ProShare Advisors's largest Q3 2017 buy was Baker Hughes: 116,604 shares worth $4.27M.
- ProShare Advisors added most to Apple in Q3 2017, an estimated $32.9M increase.
- ProShare Advisors's biggest Q3 2017 reduction was CR Bard Inc., cutting an estimated $13.1M.
- ProShare Advisors fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $16.3M.
- ProShare Advisors's ten largest holdings make up 16% of its $10.9B portfolio in Q3 2017.
- ProShare Advisors opened 18 new positions and closed 101 in Q3 2017.
- ProShare Advisors's portfolio value rose 8.4% quarter-over-quarter to $10.9B.
Based on ProShare Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.